1. Home
  2. PROV vs SLDB Comparison

PROV vs SLDB Comparison

Compare PROV & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Provident Financial Holdings Inc.

PROV

Provident Financial Holdings Inc.

N/A

Current Price

$16.00

Market Cap

98.1M

Sector

Finance

ML Signal

N/A

Logo Solid Biosciences Inc.

SLDB

Solid Biosciences Inc.

HOLD

Current Price

$5.75

Market Cap

464.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PROV
SLDB
Founded
1956
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
98.1M
464.1M
IPO Year
1996
2018

Fundamental Metrics

Financial Performance
Metric
PROV
SLDB
Price
$16.00
$5.75
Analyst Decision
Hold
Strong Buy
Analyst Count
2
11
Target Price
$16.25
$14.82
AVG Volume (30 Days)
9.1K
987.6K
Earning Date
01-27-2026
11-03-2025
Dividend Yield
3.54%
N/A
EPS Growth
N/A
N/A
EPS
0.90
N/A
Revenue
$39,823,000.00
N/A
Revenue This Year
$4.14
N/A
Revenue Next Year
$3.70
N/A
P/E Ratio
$17.59
N/A
Revenue Growth
0.07
N/A
52 Week Low
$12.98
$2.41
52 Week High
$16.70
$7.37

Technical Indicators

Market Signals
Indicator
PROV
SLDB
Relative Strength Index (RSI) 64.43 59.24
Support Level $15.01 $5.47
Resistance Level $15.58 $6.04
Average True Range (ATR) 0.37 0.34
MACD 0.10 0.08
Stochastic Oscillator 100.00 68.99

Price Performance

Historical Comparison
PROV
SLDB

About PROV Provident Financial Holdings Inc.

Provident Financial Holdings Inc is a holding company of Provident Savings Bank, F.S.B. It is a financial services company committed to serving consumers and small to mid-sized businesses in the Inland Empire region of Southern California. Its business activities consist of community banking, investment services and trustee services for real estate transactions. The group operates in Bank segment that include attracting deposits, offering banking services and originating and purchasing single-family, multi-family, commercial real estate, construction and, to a lesser extent, other mortgage, commercial business and consumer loans. Its evenues are derived from interest earned on its loan and investment portfolios, and fees generated through its community banking activities.

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.

Share on Social Networks: